Antimelanogenic Activity of Ocotillol-Type Saponins from Panax vietnamensis
- PMID: 32163220
- DOI: 10.1002/cbdv.202000037
Antimelanogenic Activity of Ocotillol-Type Saponins from Panax vietnamensis
Abstract
The ocotillol (OCT)-type saponins have been known as a tetracyclic triterpenoid, possessing five- or six-membered epoxy ring in the side chain. Interestingly, this type saponin was mostly found in Panax vietnamensis Ha et Grushv., Araliaceae (VG), hence making VG unique from the other Panax spp. Five OCT-type saponins, majonoside R2, vina-ginsenoside R2, majonoside R1, pseudoginsenoside RT4, vina-ginsenoside R11, together with three protopanaxadiol (PPD)-type saponins and four protopanaxatriol (PPT)-type saponins from VG were evaluated for their antimelanogenic activity. All of isolates were found to be active. More importantly, the five OCT-type saponins inhibited melanin production in B16-F10 mouse melanoma cells, without showing any cytotoxicity. Besides ginsenoside Rd and ginsenoside Rg3 in PPD and notoginsenoside R1 in PPT-type saponins, majonoside R2 was the most potent melanogenesis inhibitory activity in OCT-type saponins. In this article, we highlighted antimelanogenic activity of OCT-type saponins and potential structure-activity relationship (SAR) of ginsenosides. Our results suggested that OCT-type saponins could be used as a depigmentation agent.
Keywords: Panax vietnamensis; antimelanogenic activity; cytotoxicity; ocotillol-type saponins; structure-activity relationship.
© 2020 Wiley-VHCA AG, Zurich, Switzerland.
References
-
- M. G. Cappai, M. Picciau, G. Nieddu, I. Sogos, R. Cherchi, W. Pinna, ‘Cutaneous metabolic pathway of tyrosine as a precursor to melanin in Asinara's white donkey Equusa sinus L., 1758’, Ital. J. Anim. Sci. 2015, 14, 3976-3982.
-
- S. Briganti, E. Camera, M. Picardo, ‘Chemical and instrumental approaches to treat hyperpigmentation’, Pigm. Cell Res. 2003, 16, 101-110.
-
- A. Gunia-Krzyżak, J. Popiol, H. Marona, ‘Melanogenesis inhibitors: strategies for searching for and evaluation of active compounds’, Curr. Med. Chem. 2016, 23, 3548-3574.
-
- H. Wang, D. Peng, J. Xie, ‘Ginseng leaf-stem: bioactive constituents and pharmacological functions’, Chin. Med. 2009, 4, 20-28.
-
- D. Y. Lee, J. Lee, Y. T. Jeong, G. H. Byun, J. H. Kim, ‘Melanogenesis inhibition activity of floralginsenoside A from Panax ginseng berry’, J. Ginseng Res. 2017, 41, 602-607.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous